NeuBase Therapeutics (NBSE) Stock on November 23, 2025: Delisting, Liquidation Escrow and What Shareholders Still Need to Know
NeuBase Therapeutics dissolved and began liquidation after filing a Certificate of Dissolution on June 26, 2024. Nasdaq delisted NBSE in May 2024; trading was suspended and shares are no longer listed on any exchange. Shareholders received $0.13 per share and a non-tradable escrow share for potential future payouts. No active market exists, despite some data vendors still showing outdated prices.
